An Estimated 1 in 4 Medicare Beneficiaries With Obesity or Overweight Could Be Eligible for Medicare Coverage of Wegovy, an Anti-Obesity Drug, to Reduce Heart Risk

In a new analysis, KFF finds that 3.6 million people with Medicare could be eligible for coverage of Wegovy (semaglutide) now that the Food and Drug Administration has approved the…

Continue ReadingAn Estimated 1 in 4 Medicare Beneficiaries With Obesity or Overweight Could Be Eligible for Medicare Coverage of Wegovy, an Anti-Obesity Drug, to Reduce Heart Risk

Gaps in Medicare Advantage Data Remain Despite CMS Actions to Increase Transparency

The Centers for Medicare and Medicaid Services (CMS) has recently taken actions to increase transparency in Medicare Advantage, the private plan alternative to traditional Medicare that now provides Medicare coverage…

Continue ReadingGaps in Medicare Advantage Data Remain Despite CMS Actions to Increase Transparency

Millions of People with Medicare Will Benefit from the New Out-of-Pocket Drug Spending Cap Over Time

In 2025, Medicare beneficiaries will pay no more than $2,000 out of pocket for prescription drugs covered under Part D, Medicare’s outpatient drug benefit. This is due to a provision…

Continue ReadingMillions of People with Medicare Will Benefit from the New Out-of-Pocket Drug Spending Cap Over Time